Bank of New York Mellon Corp Has $18.49 Million Position in Oscar Health, Inc. (NYSE:OSCR)

Bank of New York Mellon Corp lessened its stake in shares of Oscar Health, Inc. (NYSE:OSCR) by 7.0% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 1,375,408 shares of the company’s stock after selling 103,198 shares during the quarter. Bank of New York Mellon Corp’s holdings in Oscar Health were worth $18,485,000 as of its most recent filing with the SEC.

A number of other hedge funds also recently modified their holdings of OSCR. KBC Group NV increased its position in Oscar Health by 56.1% during the fourth quarter. KBC Group NV now owns 7,107 shares of the company’s stock worth $96,000 after acquiring an additional 2,555 shares during the period. ORG Wealth Partners LLC bought a new position in Oscar Health during the fourth quarter worth about $100,000. Alberta Investment Management Corp bought a new position in Oscar Health during the fourth quarter worth about $138,000. SMART Wealth LLC bought a new position in Oscar Health during the fourth quarter worth about $180,000. Finally, Tempus Wealth Planning LLC bought a new position in Oscar Health during the fourth quarter worth about $181,000. Institutional investors and hedge funds own 75.70% of the company’s stock.

Oscar Health Price Performance

OSCR stock opened at $14.69 on Wednesday. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26. Oscar Health, Inc. has a 12 month low of $12.43 and a 12 month high of $23.79. The firm has a market cap of $3.68 billion, a P/E ratio of -733.88 and a beta of 1.75. The company’s 50-day moving average price is $15.23 and its two-hundred day moving average price is $16.47.

Oscar Health (NYSE:OSCR) last released its earnings results on Tuesday, February 4th. The company reported ($0.62) EPS for the quarter, missing the consensus estimate of ($0.55) by ($0.07). Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. On average, analysts anticipate that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Separately, Jefferies Financial Group started coverage on shares of Oscar Health in a report on Tuesday, December 10th. They issued an “underperform” rating and a $12.00 target price on the stock. Two investment analysts have rated the stock with a sell rating, two have given a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $21.56.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.